Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

CNBC - Oct 20, 2026

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

Read full article

More News

Expert Features

The Expert Features reports on the issues and the world’s everyday news. Handled by experts in different niches, you will find different subjects and perspectives.